抗癌劑Briciclib |抑制癌細胞中cyclin D1的積累
| 代理廠牌： |  |
| 原廠連結： | |
| 相關下載： |
特點
Briciclib | CAS # 865783-99-9 | BioVision Inc.
抗癌劑Briciclib 貨號B1140-25 | 25 mg
產品描述: Biovision提供一系列癌症相關分析套組；包括血管新生、細胞侵入Invasion、細胞遷移migration、抗癌劑、抗癌蛋白、癌症行為分析等分析商品。其中抗癌劑系列商品，具有高純度≥98% by HPLC且穩定的生化物質，可以使用在癌症相關的抑制劑和活化劑之研究實驗。Briciclib是一種小分子，抑制癌細胞中cyclin D1的積累。cyclin D，細胞週期蛋白家族的細胞週期調節的成員，在細胞週期分裂扮演重要角色，在各種血液和實體瘤的過度表達，並與預後不良相關。
Briciclib | CAS # 865783-99-9 | BioVision Inc.
Briciclib is a small molecule that suppresses cyclin D1 accumulation in cancer cells. Cyclin D, a member of the cyclin family of cell cycle regulators, plays a key role in cell cycle division and is often overexpressed in a variety of hematologic and solid tumors and is correlated with poor prognosis.
| Catalog # | Product Name+ | Size |
| 1862-25 | (R,S)-Lenalidomide | 25 mg |
| 1862-100 | (R,S)-Lenalidomide | 100 mg |
| 2828-5 | 2′-Deoxy-6-thioguanosine | 5 mg |
| 2828-25 | 2′-Deoxy-6-thioguanosine | 25 mg |
| 2150-100 | 3,3′-Diindolylmethane | 100 mg |
| 2150-1000 | 3,3′-Diindolylmethane | 1 g |
| 2377-10 | Amifostine | 10 mg |
| 2377-50 | Amifostine | 50 mg |
| 2519-50 | Artemisinin | 50 mg |
| 2519-250 | Artemisinin | 250 mg |
| 1552-25 | Betulinic acid | 25 mg |
| 1575-5 | Bexarotene | 5 mg |
| 1575-50 | Bexarotene | 50 mg |
| 2246-10 | Bleomycin sulfate | 10 mg |
| 2246-50 | Bleomycin sulfate | 50 mg |
| 1560-5 | Brefeldin A | 5 mg |
| B1140-5 | Briciclib | 5 mg |
| B1140-25 | Briciclib | 25 mg |
| 1741-100 | Capecitabine | 100 mg |
| 1741-1000 | Capecitabine | 1 g |
| 1553-100 | Carboplatin | 100 mg |
| 2075-5 | Carnosic Acid | 5 mg |
| 2075-25 | Carnosic Acid | 25 mg |
| 1550-100 | Cisplatin | 100 mg |
| 1550-1000 | Cisplatin | 1 g |
| 2236-5 | Clofarabine | 5 mg |
| 2236-25 | Clofarabine | 25 mg |
| 2239-10 | Combretastatin A4 | 10 mg |
| 2239-50 | Combretastatin A4 | 50 mg |
| 1815-5 | CP-31398 Dihydrochloride | 5 mg |
| 1815-25 | CP-31398 Dihydrochloride | 25 mg |
| 1578-5 | Cyclopamine | 5 mg |
| 9657-1G | Cyclophosphamide monohydrate | 1 g |
| 9657-5G | Cyclophosphamide monohydrate | 5 g |
| 2833-5 | Cytochlor | 5 mg |
| 2833-25 | Cytochlor | 25 mg |
| 1524-500 | Daunorubicin.HCl | 500 mg |
| 1524-10 | Daunorubicin.HCl | 10 mg |
| 1524-50 | Daunorubicin.HCl | 50 mg |
| B1062-25 | Diallyl trisulfide | 25 mg |
| B1062-100 | Diallyl trisulfide | 100 mg |
| 2232-10 | Docetaxel | 10 mg |
| 2232-50 | Docetaxel | 50 mg |
| 1527-5 | Doxorubicin.HCl | 5 mg |
| 9579-5 | Ellipticine | 5 mg |
| 9579-25 | Ellipticine | 25 mg |
| 1970-50 | Emetine dihydrochloride | 50 mg |
| 1970-250 | Emetine dihydrochloride | 250 mg |
| 2012-1 | Epothilone B | 1 mg |
| 2012-5 | Epothilone B | 5 mg |
| 2231-1 | Erastin | 1 mg |
| 2231-5 | Erastin | 5 mg |
| 2896-10 | Etoposide phosphate | 10 mg |
| 2896-50 | Etoposide phosphate | 50 mg |
| 1746-5 | EZSolution™ Rapamycin | 5 mg |
| 1763-10 | Fludarabine Phosphate | 10 mg |
| 1763-50 | Fludarabine Phosphate | 50 mg |
| 1564-1 | Geldanamycin | 1 mg |
| 1759-25 | Gemcitabine Hydrochloride | 25 mg |
| 1759-100 | Gemcitabine Hydrochloride | 100 mg |
| 1533-10 | Genistein | 10 mg |
| 2526-1 | Hypericin | 1 mg |
| 2526-5 | Hypericin | 5 mg |
| 2152-250 | α-Galactosylceramide | 250 µg |
| 2152-1000 | α-Galactosylceramide | 1 mg |
| 2722-50 | α-Tocopheryl succinate | 50 mg |
| 2722-250 | α-Tocopheryl succinate | 250 mg |
| 2038-100 | Ilimaquinone | 100 μg |
| 2318-5 | Imperatorin | 5 mg |
| 2318-25 | Imperatorin | 25 mg |
| 9634-5 | Iron Chelator, Dp44MT | 5 mg |
| 9634-25 | Iron Chelator, Dp44MT | 25 mg |
| 1689-05 | Jasplakinolide, jaspis johnstoni | 50 µg |
| 2408-100 | L-Selenomethionine | 100 mg |
| 2408-500 | L-Selenomethionine | 500 mg |
| 2408-1000 | L-Selenomethionine | 1 g |
| 2181-100 | Latrunculin A | 100 µg |
| 2182-1 | Latrunculin B | 1 mg |
| 1885-50 | Mitoxantrone | 50 mg |
| 1885-250 | Mitoxantrone | 250 mg |
| 1772-250 | Naringenin | 250 mg |
| 1772-1000 | Naringenin | 1 g |
| 1576-5 | Nedaplatin | 5 mg |
| 1891-5 | Nimbolide | 5 mg |
| 1891-25 | Nimbolide | 25 mg |
| 2185-10 | Nocodazole | 10 mg |
| 2185-50 | Nocodazole | 50 mg |
| 1730-25 | Oridonin | 25 mg |
| 1730-5 | Oridonin | 5 mg |
| 1577-25 | Oxaliplatin | 25 mg |
| 1567-25 | Paclitaxel | 25 mg |
| 2053-1 | Pellitorine | 1 mg |
| 2053-5 | Pellitorine | 5 mg |
| 1554-10 | Pifithrin-ɑ | 10 mg |
| 1919-10 | Piperlongumine | 10 mg |
| 1919-50 | Piperlongumine | 50 mg |
| 1988-10 | Piperlonguminine | 10 mg |
| 1988-50 | Piperlonguminine | 50 mg |
| 1958-5 | Pixantrone maleate | 5 mg |
| 1958-25 | Pixantrone maleate | 25 mg |
| 2054-10 | PK 11195 | 10 mg |
| 2054-50 | PK 11195 | 50 mg |
| 2290-50 | Plumbagin | 50 mg |
| 2290-250 | Plumbagin | 250 mg |
| 2767-50 | Podophyllotoxin | 50 mg |
| 2767-250 | Podophyllotoxin | 250 mg |
| 2311-250 | Prodigiosin | 250 µg |
| 2311-1000 | Prodigiosin | 1 mg |
| 2073-5 | Pterostilbene | 5 mg |
| 2073-25 | Pterostilbene | 25 mg |
| 2436-5 | Quinol 1h | 5 mg |
| 2436-25 | Quinol 1h | 25 mg |
| 2437-5 | Quinol 2 | 5 mg |
| 2437-25 | Quinol 2 | 25 mg |
| 1568-5 | Rapamycin | 5 mg |
| 1551-1000 | Tamoxifen citrate | 1 g |
| 2226-10 | Temozolomide | 10 mg |
| 2226-50 | Temozolomide | 50 mg |
| B1049-10 | Toremifene citrate | 10 mg |
| B1049-50 | Toremifene citrate | 50 mg |
| 1959-5 | Vinblastine Sulfate | 5 mg |
| 1959-25 | Vinblastine Sulfate | 25 mg |
| 1957-5 | Vinorelbine Tartrate | 5 mg |
| 1957-25 | Vinorelbine Tartrate | 25 mg |
| 2694-5 | VK3-OCH3 | 5 mg |
| 2694-25 | VK3-OCH3 | 25 mg |
| 9693-5 | Wogonin | 5 mg |
| 9693-25 | Wogonin | 25 mg |
| Catalog # | Product Name+ | Size |
| 2367-250 | Borrelidin | 250 µg |
| 2367-1000 | Borrelidin | 1 mg |
| 2293-10 | Castanospermine | 10 mg |
| 2293-50 | Castanospermine | 50 mg |
| 9476-5 | Foretinib | 5 mg |
| 9476-25 | Foretinib | 25 mg |
| 2368-1 | Fumagillin | 1 mg |
| 2529-5 | Isoxanthohumol | 5 mg |
| 2529-25 | Isoxanthohumol | 25 mg |
| 2610-5 | SKLB610 | 5 mg |
| 2610-25 | SKLB610 | 25 mg |
癌症行為相關商品
Invasion細胞侵入分析 | Migration細胞遷移 | 抗癌藥劑 | DIVAA活體血管新生成套組 | Warburg瓦氏效應 |